Ravi Pingali Download Headshot

Sai Ravi Pingali, M.D., MD

  • Houston Methodist hematologist oncologist
  • Hematologist oncologist, Houston Methodist Cancer Center
Media Contact: Amy Rose , 412.613.1428

Sai Ravi Pingali, M.D., MD

Request Interview
Media Contact: Amy Rose , 412.613.1428

Areas of Expertise

  • Blood cancers
  • Bone marrow transplant
  • Hematologic malignancies
  • Hodgkin’s Disease
  • Leukemia, Lymphoma
  • Myeloma
  • Stem cell transplantation

Credentials

BOARD CERTIFICATION
Medical Oncology
Hematology
MEDICAL SCHOOL
Osmania Medical College-Hyderabad, India | 2003
RESIDENCY
Internal Medicine | Gundersen Lutheran Medical Center - Lacrosse, WI | 2010
INTERNSHIP
Internal Medicine | Gundersen Lutheran Medical Center - Lacrosse, WI | 2008
FELLOWSHIP
MD Anderson Hospital - Stem Cell Transplantation - Houston, TX | 2014

Publications

LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
Mai, S, Hodges, A, Chen, HM, Zhang, J, Wang, YL, Liu, Y, Nakatsu, F, Wang, X, Fang, J, Xu, Y, Davidov, V, Kang, K, Pingali, SR, Ganguly, S, Suzuki, M, Konopleva, M, Prinzing, B, Zu, Y, Gottschalk, S, Lu, Y, Chen, SH & Pan, PY 2023, , Cancer research, vol. 83, no. 24, pp. 4047-4062. https://doi.org/10.1158/0008-5472.CAN-22-2483

Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry
Burns, EA, Sanchez, CG, Mathur, S, Guerrero, C, Muhsen, IN, Sarfraz, H, Hu, CCA, Tang, CHA, Shah, SS, Tremont, IW, Teh, B, Ganguly, S & Pingali, SRK 2023, , Annals of Hematology, vol. 102, no. 5, pp. 1111-1120. https://doi.org/10.1007/s00277-023-05140-6

Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry
Burns, EA, Wilson, JJ, Mathur, S, Kieser, R, Gong, Z, Hu, CCA, Tang, CHA, Petkova, J, Yuen, C, Mai, H, Shah, S, Rice, L, Ganguly, S & Pingali, SR 2023, , Annals of Hematology, vol. 102, no. 10, pp. 2753-2763. https://doi.org/10.1007/s00277-023-05328-w

A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors
Su, P, Xiao, L, Ye, L, Wang, Z, Xiong, W, Wang, Q, Ma, X, Xian, M, Yang, M, Zu, Y, Pingali, SR, Qian, J & Yi, Q 2022, , Journal of Hematology and Oncology, vol. 15, no. 1, 55, pp. 55. https://doi.org/10.1186/s13045-022-01269-5

RAR? activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway
Wang, Q, Lin, Z, Wang, Z, Ye, L, Xian, M, Xiao, L, Su, P, Bi, E, Huang, YH, Qian, J, Liu, L, Ma, X, Yang, M, Xiong, W, Zu, Y, Pingali, SR, Xu, B & Yi, Q 2022, , Blood, vol. 139, no. 1, pp. 59-72. https://doi.org/10.1182/blood.2020009856

Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma
Friend, BD, Muhsen, IN, Patel, S, Hill, LQC, Lulla, P, Ramos, CA, Pingali, SR, Kamble, RT, John, TD, Salem, B, Bhar, S, Doherty, EE, Craddock, J, Sasa, G, Wu, M, Wang, T, Martinez, C, Krance, RA, Heslop, HE & Carrum, G 2022, , Bone Marrow Transplantation, vol. 57, no. 4, pp. 579-585. https://doi.org/10.1038/s41409-022-01599-5


Loss of AID exacerbates the malignant progression of CLL
Lee, AC, Pingali, SR, Pinilla-Ibarz, JA, Atchison, ML, Koumenis, C, Argon, Y, Thomas-Tikhonenko, A, De Trez, C, Hu, CCA & Tang, CHA 2022, , Leukemia, vol. 36, no. 10, pp. 2430-2442. https://doi.org/10.1038/s41375-022-01663-5

Prognostic Effect of Systemic Therapy and Radiation Therapy in Stage I Nodal Marginal Zone Lymphoma
Chevli, N, Margolis, V, Haque, W, Pingali, SR, Butler, EB & Teh, BS 2023, , Practical Radiation Oncology, vol. 13, no. 1, pp. e80-e93. https://doi.org/10.1016/j.prro.2022.10.001

RAR? activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway
Wang, Q, Lin, Z, Wang, Z, Ye, L, Xian, M, Xiao, L, Su, P, Bi, E, Huang, YH, Qian, J, Liu, L, Ma, X, Yang, M, Xiong, W, Zu, Y, Pingali, SR, Xu, B & Yi, Q 2022, , Blood, vol. 139, no. 1, pp. 59-72. https://doi.org/10.1182/blood.2020009856, https://doi.org/10.1182/blood.2020009856

G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
Youssef, JG, Zahiruddin, F, Youssef, G, Padmanabhan, S, Ensor, J, Pingali, SR, Zu, Y, Sahay, S & Iyer, SP 2021, , Annals of Hematology, vol. 100, no. 3, pp. 667-673. https://doi.org/10.1007/s00277-021-04395-1

Yeni jenerasyon proteozom inhibitörleriyle olan çevresel nöropati yükünün fda yan etki raporlama sistemi kullanilarak pazarlama sonrasi analizi
Mina, SA, Muhsen, IN, Burns, EA, Sarfraz, H, Pingali, SR, Xu, J & Hashmi, SK 2021, , Turkish Journal of Hematology, vol. 38, no. 3, pp. 218-221. https://doi.org/10.4274/tjh.galenos.2021.2021.0052

Primary cutaneous anaplastic large-cell lymphoma: a review of the SEER database from 2005 to 2016
Sarfraz, H, Gentille, C, Ensor, J, Wang, L, Wong, S, Ketcham, MS, Joshi, J & Pingali, SRK 2021, , Clinical and Experimental Dermatology, vol. 46, no. 8, pp. 1420-1426. https://doi.org/10.1111/ced.14777

Clinical Outcomes Following Tocilizumab Administration in Mechanically Ventilated Coronavirus Disease 2019 Patients
Sirimaturos, M, Gotur, DB, Patel, SJ, Dreucean, D, Jakowenko, N, Cooper, MH, Brahmbhatt, N, Graviss, EA, Nguyen, DT, Pingali, SR, Lin, J & Musick, WL 2020, , Critical care explorations, vol. 2, no. 10, pp. e0232. https://doi.org/10.1097/CCE.0000000000000232

Clinical Outcomes Following Tocilizumab Administration in Mechanically Ventilated Coronavirus Disease 2019 Patients
Sirimaturos, M, Gotur, DB, Patel, SJ, Dreucean, D, Jakowenko, N, Cooper, MH, Brahmbhatt, N, Graviss, EA, Nguyen, DT, Pingali, SR, Lin, J & Musick, WL 2020, , Critical care explorations, vol. 2, no. 10, pp. E0232. https://doi.org/10.1097/CCE.0000000000000232

Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors
Anand, K, Sahu, G, Burns, E, Ensor, A, Ensor, J, Pingali, SR, Subbiah, V & Iyer, SP 2020, , ESMO Open, vol. 5, no. 4, e000866. https://doi.org/10.1136/esmoopen-2020-000866

Recurrent small bowel obstruction caused by Burkitt lymphoma in an elderly man: A case report and review of the literature
Kasparian, S, Burns, E, Shehabeldin, A, Awar, M & Pingali, SR 2020, , Journal of Medical Case Reports, vol. 14, no. 1, 127. https://doi.org/10.1186/s13256-020-02449-y

Radiation therapy in primary mediastinal large B-cell lymphoma treated with DA-R-EPOCH
Gentille, C, Anand, K, Dalwadi, S, Puri, A, Farach, A & Pingali, SR 2020, , Clinical Case Reports, vol. 8, no. 7, pp. 1153-1155. https://doi.org/10.1002/ccr3.2853

MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma
Wang, Q, Zhao, D, Xian, M, Wang, Z, Bi, E, Su, P, Qian, J, Ma, X, Yang, M, Liu, L, Zu, Y, Pingali, SR, Chen, K, Cai, Z & Yi, Q 2020, , Blood, vol. 136, no. 22, pp. 2557-2573. https://doi.org/10.1182/blood.2020005795

T-cell lymphoma secondary to checkpoint inhibitor therapy
Anand, K, Ensor, Jr. JE, Pingali, SR, Hwu, P, Duvic, M, Chiang, S, Miranda, R, Zu, Y & Iyer, S 2020, , Journal for immunotherapy of cancer, vol. 8, no. 1, e000104. https://doi.org/10.1136/jitc-2019-000104

Languages

  • English
  • Hindi
  • Telugu